New York, New York and Framingham, Massachusetts–(Newsfile Corp. – January 12, 2026) – NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor (MMR) and technology company focused on developing clean energy solutions, today announced that it has signed a Memorandum of Understanding (MOU) with Ameresco, Inc. […]

Apptegy announces Community Experience, the AI-powered communication hub for K-12, which integrates AI search, chat, task management, and analytics into a single, district-branded platform. Launching in Q1 2026, this solution is designed to give families instant, accurate answers, streamline staff workflows, and provide district leaders with real-time community insights. Apptegy today announced Community Experience, an

Quantum Computing Inc. (“QCi” or the “Company”) (Nasdaq: QUBT), an innovative quantum optics and integrated photonics technology company, today announced that, following its previously announced agreement to acquire Luminar Semiconductor, Inc. (“LSI”), it has submitted a bid and has been selected as the stalking horse bidder for selected remaining assets of Luminar Technologies, Inc. (“Luminar”).

Chairman Tom Lee urges stockholders to vote YES to proposal #2 to support Bitmine’s goal of growing ETH per share Stockholders can find the latest information around voting YES and the Chairman’s message on the Bitmine website Bitmine staked ETH stands at 1,256,083 and MAVAN staking solution on track to launch Q1 2026 Bitmine remains

In this free webinar, gain insight into the antibody-drug conjugate (ADC) therapeutic landscape and pipeline. Attendees will be introduced to global site selection, preparedness and training required for successful ADC development. The featured speakers will discuss dose optimization and safety monitoring, including capturing long-term outcomes. Attendees will learn about incorporating the patient voice into protocol

In this free webinar, learn how recombinant insulin improves viral production across diverse vaccine platforms. Attendees will gain insight into the role of recombinant trypsin in efficient cell dissociation and improved virus infectivity and quality. The featured speakers will discuss how the implementation of recombinant insulin and trypsin enhances safety, improves efficiency and enables cost-effective

Accelerating AI-enabled acute-care diagnostics by years and millions of dollars — MeMed, the leader in host-response diagnostics, announced it has been awarded a competitive national grant through the IIA to establish an acute-care diagnostics and proteomics biobank, as part of a nationwide AI R&D data infrastructure. This initiative significantly accelerates the development and validation of

Company experiencing strong demand in the U.S. following FDA marketing authorization of ProSense® as the only on-label minimally invasive solution for the local treatment of low-risk breast cancer, addressing a market opportunity of approximately 200,000 patients Record European sales, driven by positive effects of U.S. clearance and continued growing adoption of ProSense® cryoablation for breast

Showcasing a complete hardware and software product portfolio ecosystem designed to adapt to diverse environments and needs Promethean, a global education and workplace technology company and a brand of Mynd.ai (NYSE American: MYND), today announced its participation in major international trade shows taking place January through March 2026. At these events, Promethean will demonstrate its

Vision Marine Technologies Inc. (NASDAQ: VMAR), today announced that the Company’s board of directors (the “Board”) approved 1 for 40 reverse stock split of the Company’s common shares. The reverse stock split is expected to become effective when the market opens on January 14, 2026 (the “Effective Date”) and the Company’s common shares will begin